Biomarkers in Cancer Research

A malignancy biomarker alludes to a substance or procedure that is characteristic of the nearness of disease in the body. A biomarker might be an atom emitted by a tumor or a particular reaction of the body to the nearness of malignant growth. Hereditary, epigenetic, proteomic, glycomic, and imaging biomarkers can be utilized for malignancy finding, guess, and the study of disease transmission. In a perfect world, such biomarkers can be tested in non-intrusively gathered biofluids like blood or serum.

  • Imaging Biomarkers
  • Clinical Biomarkers
  • Genetic Biomarkers
  • Predictive Cancer Biomarkers
  • Molecular Biomarkers

Related Conference of Biomarkers in Cancer Research

July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
August 18-19, 2025

6th Cancer Diagnostics & Treatment Conference

Rome, Italy
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 20-21, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Aix-en-Provence, France
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France

Biomarkers in Cancer Research Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in